The maintenance of an Outperform rating combined with an increase in the price target by a reputable analyst like Sean Dodge of RBC Capital is likely to be viewed positively by the market. This endorsement reflects confidence in HealthEquity's future performance, potentially leading to increased investor interest and a positive short-term impact on the stock price.